Electrochemotherapy in head and neck cancer: A review of an emerging cancer treatment (Review)
- Authors:
- Armando De Virgilio
- Massimo Ralli
- Lucia Longo
- Patrizia Mancini
- Giuseppe Attanasio
- Francesca Atturo
- Marco De Vincentiis
- Antonio Greco
-
Affiliations: Department of Otolaryngology, Humanitas Clinical and Research Center, I‑20089 Milan, Italy, Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, I‑00186 Rome, Italy, Department of Sense Organs, Sapienza University of Rome, I‑00186 Rome, Italy - Published online on: July 12, 2018 https://doi.org/10.3892/ol.2018.9140
- Pages: 3415-3423
This article is mentioned in:
Abstract
 |
|
Miklavcic D and Davalos RV: Electrochemotherapy (ECT) and irreversible electroporation (IRE) -advanced techniques for treating deep-seated tumors based on electroporation. Biomed Eng Online. 14 Suppl 3:I12015. View Article : Google Scholar : PubMed/NCBI | |
|
Groselj A, Kos B, Cemazar M, Urbancic J, Kragelj G, Bosnjak M, Veberic B, Strojan P, Miklavcic D and Sersa G: Coupling treatment planning with navigation system: A new technological approach in treatment of head and neck tumors by electrochemotherapy. Biomed Eng Online. 14 Suppl 3:S22015. View Article : Google Scholar : PubMed/NCBI | |
|
Mir LM, Orlowski S, Belehradek J Jr and Paoletti C: Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer. 27:68–72. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Heller R, Gilbert R and Jaroszeski MJ: Clinical applications of electrochemotherapy. Adv Drug Deliv Rev. 35:119–129. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Heller R, Gilbert R and Jaroszeski MJ: Electrochemotherapy: An emerging drug delivery method for the treatment of cancer. Adv Drug Deliv Rev. 26:185–197. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Mir LM, Banoun H and Paoletti C: Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res. 175:15–25. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R and Heller R: Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs. 11:201–208. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Rols MP, Delteil C, Golzio M, Dumond P, Cros S and Teissie J: In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol. 16:168–171. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM, Delaere P, Branellec D, Schwartz B and Scherman D: High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA. 96:4262–4267. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Heller R, Jaroszeski M, Atkin A, Moradpour D, Gilbert R, Wands J and Nicolau C: In vivo gene electroinjection and expression in rat liver. FEBS Lett. 389:225–228. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA and Glass LF: Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer. 83:148–157. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Orlowski S and Mir LM: Cell electropermeabilization: A new tool for biochemical and pharmacological studies. Biochim Biophys Acta. 1154:51–63. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Weaver JC: Electroporation: A general phenomenon for manipulating cells and tissues. J Cell Biochem. 51:426–435. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Edd JF, Horowitz L, Davalos RV, Mir LM and Rubinsky B: In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng. 53:1409–1415. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Nuccitelli R, Pliquett U, Chen X, Ford W, Swanson James R, Beebe SJ, Kolb JF and Schoenbach KH: Nanosecond pulsed electric fields cause melanomas to self-destruct. Biochem Biophys Res Commun. 343:351–360. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Weaver JC: Electroporation theory. Concepts and mechanisms. Methods Mol Biol. 55:3–28. 1995.PubMed/NCBI | |
|
Neumann E, Schaefer-Ridder M, Wang Y and Hofschneider PH: Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1:841–845. 1982.PubMed/NCBI | |
|
Pron G, Belehradek J Jr and Mir LM: Identification of a plasma membrane protein that specifically binds bleomycin. Biochem Biophys Res Commun. 194:333–337. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Mir LM, Tounekti O and Orlowski S: Bleomycin: Revival of an old drug. Gen Pharmacol. 27:745–748. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Gehl J, Skovsgaard T and Mir LM: Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs. Anticancer Drugs. 9:319–325. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Orlowski S, Belehradek J Jr, Paoletti C and Mir LM: Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol. 37:4727–4733. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Poddevin B, Orlowski S, Belehradek J Jr and Mir LM: Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol. 42 Suppl:S67–S75. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Hall SW, Strong JE, Broughton A, Frazier ML and Benjamin RS: Bleomycin clinical pharmacology by radioimmunoassay. Cancer Chemother Pharmacol. 9:22–25. 1982. View Article : Google Scholar : PubMed/NCBI | |
|
Eljack ND, Ma HY, Drucker J, Shen C, Hambley TW, New EJ, Friedrich T and Clarke RJ: Mechanisms of cell uptake and toxicity of the anticancer drug cisplatin. Metallomics. 6:2126–2133. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sersa G, Cemazar M and Miklavcic D: Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res. 55:3450–3455. 1995.PubMed/NCBI | |
|
Rodriguez-Cuevas S, Barroso-Bravo S, Almanza-Estrada J, Cristobal-Martinez L and Gonzalez-Rodriguez E: Electrochemotherapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin. Arch Med Res. 32:273–276. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Burian M, Formanek M and Regele H: Electroporation therapy in head and neck cancer. Acta Otolaryngol. 123:264–268. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Umezawa H, Maeda K, Takeuchi T and Okami Y: New antibiotics, bleomycin A and B. J Antibiot (Tokyo). 19:200–209. 1966.PubMed/NCBI | |
|
Dillman RO: Rationales for combining chemotherapy and biotherapy in the treatment of cancer. Mol Biother. 2:201–207. 1990.PubMed/NCBI | |
|
Tounekti O, Pron G, Belehradek J Jr and Mir LM: Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res. 53:5462–5469. 1993.PubMed/NCBI | |
|
Tounekti O, Kenani A, Foray N, Orlowski S and Mir LM: The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway. Br J Cancer. 84:1272–1279. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J Jr and Mir LM: Electrochemotherapy, a new antitumor treatment. First clinical phase I–II trial. Cancer. 72:3694–3700. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin B, Belehradek J Jr, Schwaab G, Luboinski B and Paoletti C: Electrochemotherapy, a new antitumor treatment: first clinical trial. C R Acad Sci III. 313:613–618. 1991.(In French). PubMed/NCBI | |
|
Sersa G, Cufer T, Cemazar M, Rebersek M and Zvonimir R: Electrochemotherapy with bleomycin in the treatment of hypernephroma metastasis: Case report and literature review. Tumori. 86:163–165. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Puc M, Corovic S, Flisar K, Petkovsek M, Nastran J and Miklavcic D: Techniques of signal generation required for electropermeabilization. Survey of electropermeabilization devices. Bioelectrochemistry. 64:113–124. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Mir LM, Glass LF, Sersa G, Teissié J, Domenge C, Miklavcic D, Jaroszeski MJ, Orlowski S, Reintgen DS, Rudolf Z, et al: Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer. 77:2336–2342. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Mir LM, Gehld J, Sersae G, et al: Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator by means of invasive or non-invasive electrodes. EJC Supplements. 4:14–25. 2006. View Article : Google Scholar | |
|
Miklavcic D, Corovic S, Pucihar G and Pavselj N: Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. Eur J Cancer Suppl. 4:45–51. 2006. View Article : Google Scholar | |
|
Domenge C, Orlowski S, Luboinski B, De Baere T, Schwaab G, Belehradek J Jr and Mir LM: Antitumor electrochemotherapy: New advances in the clinical protocol. Cancer. 77:956–963. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Sersa G, Stabuc B, Cemazar M, Miklavcic D and Rudolf Z: Electrochemotherapy with cisplatin: The systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases. Melanoma Res. 10:381–385. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Cemazar M, Milacic R, Miklavcic D, Dolzan V and Sersa G: Intratumoral cisplatin administration in electrochemotherapy: Antitumor effectiveness, sequence dependence and platinum content. Anticancer Drugs. 9:525–530. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Heller R, Jaroszeski M, Perrott R, Messina J and Gilbert R: Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res. 7:10–18. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Mir LM: Electroporation-based gene therapy: Recent evolution in the mechanism description and technology developments. Methods Mol Biol. 1121:3–23. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sersa G, Cemazar M, Parkins CS and Chaplin DJ: Tumour blood flow changes induced by application of electric pulses. Eur J Cancer. 35:672–677. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Gehl J and Geertsen PF: Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res. 10:585–589. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Cemazar M, Parkins CS, Holder AL, Chaplin DJ, Tozer GM and Sersa G: Electroporation of human microvascular endothelial cells: Evidence for an anti-vascular mechanism of electrochemotherapy. Br J Cancer. 84:565–570. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Mir LM, Orlowski S, Poddevin B and Belehradek J Jr: Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw. 3:331–334. 1992.PubMed/NCBI | |
|
Orlowski S, An D, Belehradek J Jr and Mir LM: Antimetastatic effects of electrochemotherapy and of histoincompatible interleukin-2-secreting cells in the murine Lewis lung tumor. Anticancer Drugs. 9:551–556. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Mir LM, Roth C, Orlowski S, Quintin-Colonna F, Fradelizi D, Belehradek J Jr and Kourilsky P: Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother Emphasis Tumor Immunol. 17:30–38. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Ramirez LH, Orlowski S, An D, Bindoula G, Dzodic R, Ardouin P, Bognel C, Belehradek J Jr, Munck JN and Mir LM: Electrochemotherapy on liver tumours in rabbits. Br J Cancer. 77:2104–2111. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Heller L, Pottinger C, Jaroszeski MJ, Gilbert R and Heller R: In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity. Melanoma Res. 10:577–583. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Sersa G, Cemazar M, Menart V, Gaberc-Porekar V and Miklavcic D: Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice. Cancer Lett. 116:85–92. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Allegretti JP and Panje WR: Electroporation therapy for head and neck cancer including carotid artery involvement. Laryngoscope. 111:52–56. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
De Virgilio A, Fusconi M, Greco A and de Vincentiis M: The role of electrochemotherapy in the treatment of metastatic head and neck cancer. Tumori. 99:6342013. View Article : Google Scholar : PubMed/NCBI | |
|
Rols MP, Bachaud JM, Giraud P, Chevreau C, Roche H and Teissie J: Electrochemotherapy of cutaneous metastases in malignant melanoma. Melanoma Res. 10:468–474. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Snoj M, Cemazar M, Kolar Slekovec B and Sersa G: Effective treatment of multiple unresectable skin melanoma metastases by electrochemotherapy. Croat Med J. 48:391–395. 2007.PubMed/NCBI | |
|
Wapnir IL, Wartenberg DE and Greco RS: Three dimensional staging of breast cancer. Breast Cancer Res Treat. 41:15–19. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Tomayko MM and Reynolds CP: Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol. 24:148–154. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, Fenske NA, Gilbert RA, Mir LM and Reintgen DS: Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer. 77:964–971. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Kubota Y, Mir LM, Nakada T, Sasagawa I, Suzuki H and Aoyama N: Successful treatment of metastatic skin lesions with electrochemotherapy. J Urol. 160:14261998. View Article : Google Scholar : PubMed/NCBI | |
|
Glass LF, Pepine ML, Fenske NA, Jaroszeski M, Reintgen DS and Heller R: Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol. 132:1353–1357. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Mali B, Jarm T, Snoj M, Sersa G and Miklavcic D: Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis. Eur J Surg Oncol. 39:4–16. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Marty M, Sersa G and Garbay JR: Electrochemotherapy-An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl. 4:3–13. 2006. View Article : Google Scholar | |
|
Sersa G: The state-of-the-art of electrochemotherapy before the ESOPE study: Advantages and clinical uses. Eur J Cancer Suppl. 4:52–59. 2006. View Article : Google Scholar | |
|
Bertino G, Sersa G, De Terlizzi F, Occhini A, Plaschke CC, Groselj A, Langdon C, Grau JJ, McCaul JA, Heuveling D, et al: European research on electrochemotherapy in head and neck Cancer (EURECA) project: Results of the treatment of skin cancer. Eur J Cancer. 63:41–52. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Plaschke CC, Bertino G, McCaul JA, Grau JJ, de Bree R, Sersa G, Occhini A, Groselj A, Langdon C, Heuveling DA, et al: European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results from the treatment of mucosal cancers. Eur J Cancer. 87:172–181. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Panje WR, Hier MP, Garman GR, Harrell E, Goldman A and Bloch I: Electroporation therapy of head and neck cancer. Ann Otol Rhinol Laryngol. 107:779–785. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Rabussay DP, Nanda GS and Goldfarb PM: Enhancing the effectiveness of drug-based cancer therapy by electroporation (electropermeabilization). Technol Cancer Res Treat. 1:71–82. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Bloom DC and Goldfarb PM: The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol. 31:1029–1035. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Larkin JO, Collins CG, Aarons S, Tangney M, Whelan M, O'Reily S, Breathnach O, Soden DM and O'Sullivan GC: Electrochemotherapy: Aspects of preclinical development and early clinical experience. Ann Surg. 245:460–479. 2007. View Article : Google Scholar | |
|
Gargiulo M, Papa A, Capasso P, Moio M, Cubicciotti E and Parascandolo S: Electrochemotherapy for non-melanoma head and neck cancers: Clinical outcomes in 25 patients. Ann Surg. 255:1158–1164. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mevio N, Bertino G, Occhini A, Scelsi D, Tagliabue M, Mura F and Benazzo M: Electrochemotherapy for the treatment of recurrent head and neck cancers: Preliminary results. Tumori. 98:308–313. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Seccia V, Muscatello L, Dallan I, Bajraktari A, Briganti T, Ursino S, Galli L, Falcone A and Sellari-Franceschini S: Electrochemotherapy and its controversial results in patients with head and neck cancer. Anticancer Res. 34:967–972. 2014.PubMed/NCBI | |
|
Campana LG, Bertino G, Rossi CR, Occhini A, Rossi M, Valpione S and Benazzo M: The value of electrochemotherapy in the treatment of peristomal tumors. Eur J Surg Oncol. 40:260–262. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Campana LG, Mali B, Sersa G, Valpione S, Giorgi CA, Strojan P, Miklavcic D and Rossi CR: Electrochemotherapy in non-melanoma head and neck cancers: A retrospective analysis of the treated cases. Br J Oral Maxillofac Surg. 52:957–964. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Macri GF, Greco A, Gallo A, Fusconi M, Marinelli C and de Vincentiis M: Use of electrochemotherapy in a case of neck skin metastasis of oral squamous cell carcinoma: Case report and considerations. Head Neck. 36:E86–E90. 2014.PubMed/NCBI | |
|
Domanico R, Trapasso S, Santoro M, Pingitore D and Allegra E: Electrochemotherapy in combination with chemoradiotherapy in the treatment of oral carcinomas in advanced stages of disease: efficacy, safety, and clinical outcomes in a small number of selected cases. Drug Des Devel Ther. 9:1185–1191. 2015.PubMed/NCBI | |
|
Landstrom FJ, Reizenstein JA, Nilsson CO, Beckerath MV, Löfgren AL, Adamsson GB and Möller C: Electrochemotherapy-possible benefits and limitations to its use in the head and neck region. Acta Otolaryngol. 135:90–95. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Landstrom FJ, Reizenstein J, Adamsson GB, Beckerath Mv and Möller C: Long-term follow-up in patients treated with curative electrochemotherapy for cancer in the oral cavity and oropharynx. Acta Otolaryngol. 135:1070–1078. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Rotunno R, Marenco F, Ribero S, Calvieri S, Amerio P, Curatolo P and Quaglino P: Electrochemotherapy in non-melanoma head and neck skin cancers: a three-center experience and review of the literature. G Ital Dermatol Venereol. 151:610–618. 2016.PubMed/NCBI | |
|
Montuori M, Santurro L, Feliziani A, DE Sanctis F, Ricciardi E, Gaudio D, Campione E, Bianchi L, Silvi MB and Rossi P: Electrochemotherapy for basocellular and squamocellular head and neck cancer: preliminary experience in Day Surgery Unit. G Ital Dermatol Venereol. 153:19–25. 2018.PubMed/NCBI | |
|
Groselj A, Bosnjak M, Strojan P, Krzan M, Cemazar M and Sersa G: Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary results. Head Neck. 40:120–25. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Guida M, Campana LG, Curatolo P, Strippoli S, Bonadies A, Grilz G, Cabula C, Rotunno R, Bucher S, Solari N, et al: Local treatment with electrochemotherapy of superficial angiosarcomas: Efficacy and safety results from a multi-institutional retrospective study. J Surg Oncol. 114:246–253. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Jahangeer S, Forde P, Soden D and Hinchion J: Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours. Cancer Treat Rev. 39:862–871. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sersa G, Cufer T, Paulin SM, Cemazar M and Snoj M: Electrochemotherapy of chest wall breast cancer recurrence. Cancer Treat Rev. 38:379–386. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Calvet CY and Mir LM: The promising alliance of anti-cancer electrochemotherapy with immunotherapy. Cancer Metastasis Rev. 35:165–177. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lenzi R, Muscatello L, Saibene AM, Felisati G and Pipolo C: The controversial role of electrochemotherapy in head and neck cancer: A systematic review of the literature. Eur Arch Otorhinolaryngol. 274:2389–2394. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Miklavčič D, Serša G, Brecelj E, Gehl J, Soden D, Bianchi G, Ruggieri P, Rossi CR, Campana LG and Jarm T: Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput. 50:1213–1225. 2012. View Article : Google Scholar : PubMed/NCBI |
